PACS Group, Inc. (PACS) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $109.33M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $120.03M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income $86.27M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income $80.50M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2023-03-31 to 2024-09-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | $109.33M | (m) | $1.43B | (m) | (m) | $135.51M* | (m) | (m) | (m) | $29.49M |
|---|
| 2026-03-31 | Reported | (m) | $120.03M | (m) | $1.42B | (m) | (m) | $236.34M | (m) | (m) | (m) | $33.07M |
|---|
| 2025-09-30 | Reported | (m) | $86.27M | (m) | $1.34B | (m) | (m) | $204.80M* | (m) | (m) | (m) | $23.97M |
|---|
| 2025-06-30 | Reported | (m) | $80.50M | (m) | $1.31B | (m) | (m) | $52.57M* | (m) | (m) | (m) | $27.65M |
|---|
| 2025-03-31 | Reported | (m) | $48.14M | (m) | $1.28B | (m) | (m) | $150.24M | (m) | (m) | (m) | $14.35M |
|---|
| 2024-09-30 | Reported | $33.49M | (m) | (m) | (m) | 3.27% | (m) | $209.23M* | $849.60M | (m) | (m) | $17.45M |
|---|
| 2024-06-30 | Reported | -$28.4M | (m) | (m) | (m) | -3.04% | (m) | $34.77M* | $762.15M | (m) | (m) | -$19.12M |
|---|
| 2024-03-31 | Reported | $73.21M | (m) | (m) | (m) | 7.96% | (m) | $58.75M | $735.99M | (m) | (m) | $22.88M |
|---|
| 2023-09-30 | Reported | $42.76M | (m) | (m) | (m) | 5.42% | (m) | $15.19M* | $638.49M | (m) | (m) | $7.47M |
|---|
| 2023-06-30 | Reported | $55.7M | (m) | (m) | (m) | 7.32% | (m) | -$21.08M* | $590.82M | (m) | (m) | $10.37M |
|---|
| 2023-03-31 | Reported | $65.12M | (m) | (m) | (m) | 9.20% | (m) | $79.29M | $538.77M | (m) | (m) | $11.50M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | $309.60M | (m) | $5.29B | (m) | (m) | $404.22M | (m) | (m) | (m) | $92.99M |
|---|
| 2024-12-31 | Reported | (m) | $123.07M | (m) | $4.09B | (m) | (m) | $367.34M | (m) | (m) | (m) | $46.21M |
|---|
| 2023-12-31 | Reported | (m) | $207.77M | (m) | $3.11B | (m) | (m) | $63.70M | (m) | (m) | (m) | $44.44M |
|---|
| 2022-12-31 | Reported | (m) | $229.36M | (m) | $2.40B | (m) | (m) | $92.61M | (m) | (m) | (m) | $56.55M |
|---|